The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Biallelic TSC gene inactivation in tuberous sclerosis complex
Open accessAbstract
BACKGROUND: A pivotal developmental question is whether tubers in tuberous sclerosis complex (TSC) form by germline and somatic TSC1 or TSC2 gene mutations. Loss of TSC1 or TSC2 in vitro and in vivo leads to mTORC1 cascade activation and ribosomal protein S6 phosphorylation (P-S6). Giant cells (GCs) in tubers exhibit S6 phosphorylation, suggesting cell-specific loss of TSC gene function. METHODS: TSC1 and TSC2 gene mutations were investigated in DNA extracted from tuber sections (n = 6) and microdissected P-S6-labeled GCs by sequencing and loss of heterozygosity (LOH) analysis to define germline and somatic mutations. RESULTS: A germline TSC1 mutation was defined in 1 case and TSC2 mutations were defined in 5 cases. LOH was not detected in whole tuber sections or microdissected P-S6-labeled GCs. TSC1 and TSC2 were sequenced in microdissected P-S6-immunolabeled GCs. In 5 specimens, a somatic mutation was identified in single GCs that was not detected in whole tuber sections or leukocyte DNA. Four somatic mutations were novel variants (1 nonsense and 3 missense mutations) and 1 additional nonsense somatic mutation was previously reported as a germline mutation. In 1 case, no somatic mutation was identified. There was reduced expression of TSC1 or TSC2 transcripts in the TSC1 or TSC2 associated specimens. In the cases containing a nonsense mutation, no transcript mRNA was detected, suggesting nonsense-mediated degradation. CONCLUSIONS: We provide evidence to support the hypothesis that tubers form by biallelic TSC1 or TSC2 gene inactivation reflecting a "2-hit" mechanism of germline and somatic mutational events. AML = angiomyolipoma; DN = dysplastic neuron; FFPE = formalin fixed, paraffin embedded; GC = giant cell; H-E = hematoxylin and eosin; LOH = loss of heterozygosity; TSC = tuberous sclerosis complex.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Second-hit mutations are frequently observed in TSC-related hamartomas and have been identified in some resected tubers from patients14,21,22,23.”
From mTORC1 drives cell-autonomous astrocyte reactivity in tuberous sclerosis (2026) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
The Tuberous Sclerosis Complex
Crino, P. B., Nathanson, K. L., & Henske, E. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055323 · Cited by 1,793
Self-citationIdentification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34
Slegtenhorst, M. V., Hoogt, R. D., Hermans, C., Nellist, M., Janssen, B., Verhoef, S., Lindhout, D., Ouweland, A. V. D., Halley, D., Young, J., et al. (1997) · Science · doi:10.1126/science.277.5327.805 · Cited by 1,648
Identification and characterization of the tuberous sclerosis gene on chromosome 16
(1993) · Cell · doi:10.1016/0092-8674(93)90618-z · Cited by 1,645
Dabora, S. L., Jóźwiak, S., Franz, D. N., Roberts, P. S., Nieto, A., Chung, J., Choy, Y.-S., Reeve, M. P., Thiele, E. A., Egelhoff, J. C., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/316951 · Cited by 998
Tee, A. R., Fingar, D. C., Manning, B. D., Kwiatkowski, D. J., Cantley, L. C., & Blenis, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202476899 · Cited by 827
Tsc tumour suppressor proteins antagonize amino-acid–TOR signalling
Gao, X., Zhang, Y., Arrazola, P., Hino, O., Kobayashi, T., Yeung, R. S. W., Ru, B., & Pan, D. (2002) · Nature Cell Biology · doi:10.1038/ncb847 · Cited by 689
Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2
Tavazoie, S. F., Alvarez, V. A., Ridenour, D. A., Kwiatkowski, D. J., & Sabatini, B. L. (2005) · Nature Neuroscience · doi:10.1038/nn1566 · Cited by 497
Meikle, L., Talos, D. M., Onda, H., Pollizzi, K., Rotenberg, A., Sahin, M., Jensen, F. E., & Kwiatkowski, D. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5540-06.2007 · Cited by 462
Au, K. S., Williams, A. T., Roach, E. S., Batchelor, L. L., Sparagana, S. P., Delgado, M. R., Wheless, J. W., Baumgartner, J. E., Roa, B. B., Wilson, C. M., et al. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e31803068c7 · Cited by 453
Cited by
Sorted by citations
Henske, E. P., Jóźwiak, S., Kingswood, J. C., Sampson, J. R., & Thiele, E. A. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.35 · Cited by 886
Lipton, J. O., & Şahin, M. (2014) · Neuron · doi:10.1016/j.neuron.2014.09.034 · Cited by 771
D’Gama, A. M., Woodworth, M. B., Hossain, A. A., Bizzotto, S., Hatem, N. E., LaCoursiere, C. M., Najm, I., Ying, Z., Yang, E., Barkovich, A. J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.106 · Cited by 333
The mTOR signalling cascade: paving new roads to cure neurological disease
Crino, P. B. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.81 · Cited by 368
Self-citationmTOR signaling and its roles in normal and abnormal brain development
Takei, N., & Nawa, H. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00028 · Cited by 317
Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations
Baulac, S., Ishida, S., Marsan, E., Miquel, C., Biraben, A., Nguyen, D., Nordli, D., Cossette, P., Nguyen, S., Lambrecq, V., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24368 · Cited by 279
Somatic overgrowth disorders of the PI3K/AKT/mTOR pathway & therapeutic strategies
Keppler‐Noreuil, K. M., Parker, V. E. R., Darling, T. N., & Martinez‐Agosto, J. A. (2016) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.31531 · Cited by 270
Magri, L., Cambiaghi, M., Cominelli, M., Alfaro‐Cervelló, C., Cursi, M., Pala, M., Bulfone, A., García‐Verdugo, J. M., Leocani, L., Minicucci, F., et al. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.09.008 · Cited by 264
Somatic mosaicism and neurodevelopmental disease
D’Gama, A. M., & Walsh, C. A. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0257-3 · Cited by 249
Abnormal mTOR Activation in Autism
Winden, K. D., Ebrahimi‐Fakhari, D., & Şahin, M. (2018) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-080317-061747 · Cited by 232
Genetically engineered human cortical spheroid models of tuberous sclerosis
Blair, J. D., Hockemeyer, D. F., & Bateup, H. S. (2018) · Nature Medicine · doi:10.1038/s41591-018-0139-y · Cited by 205
Reith, R. M., McKenna, J., Wu, H. C., Hashmi, S. S., Cho, S., Dash, P. K., & Gambello, M. J. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.10.014 · Cited by 193
mTOR Signaling in Epilepsy: Insights from Malformations of Cortical DevelopmentPreprint
Crino, P. B. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022442 · Cited by 188
Self-citationGoto, J., Talos, D. M., Klein, P., Qin, W., Chekaluk, Y. I., Anderl, S., Malinowska, I. A., Nardo, A. D., Bronson, R. T., Chan, J. A.-W., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106454108 · Cited by 176
Feliciano, D. M., Su, T. Y., López, J. M., Platel, J., & Bordey, A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44909 · Cited by 174
Genetic and Biologic Classification of Infantile Spasms
Paciorkowski, A. R., Thio, L. L., & Dobyns, W. B. (2011) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2011.08.010 · Cited by 167
Malformations of Cortical Development and EpilepsyPreprint
Barkovich, A. J., Dobyns, W. B., & Guerrini, R. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022392 · Cited by 174
Familial cortical dysplasia caused by mutation in the mammalian target of rapamycin regulator NPRL3
Sim, J. C. H., Scerri, T., Fanjul-Fernández, M., Riseley, J. R., Gillies, G., Pope, K., van Roozendaal, H., Heng, J., Mandelstam, S., McGillivray, G., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24502 · Cited by 135
Self-citationFocal Cortical Dysplasia: Gene Mutations, Cell Signaling, and Therapeutic Implications
Iffland, P. H., & Crino, P. B. (2017) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100138 · Cited by 152
Self-citationEvolving neurobiology of tuberous sclerosis complex
Crino, P. B. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1085-x · Cited by 139
Self-citationMegalencephaly and hemimegalencephaly: Breakthroughs in molecular etiology
Mirzaa, G., & Poduri, A. (2014) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31401 · Cited by 136
Genetics of tuberous sclerosis complex: implications for clinical practice
Cabán, C. T., Khan, N., Hasbani, D. M., & Crino, P. B. (2016) · The Application of Clinical Genetics · doi:10.2147/tacg.s90262 · Cited by 131
Self-citationLozovaya, N., Gataullina, S., Tsintsadze, T. S., Tsintsadze, V., Pallesi‐Pocachard, E., Minlebaev, M., Goriounova, N. A., Buhler, E., Watrin, F., Shityakov, S., et al. (2014) · Nature Communications · doi:10.1038/ncomms5563 · Cited by 125
Epilepsy in the mTORopathies: opportunities for precision medicine
Moloney, P. B., Cavalleri, G. L., & Delanty, N. (2021) · Brain Communications · doi:10.1093/braincomms/fcab222 · Cited by 125
Costa, V., Aigner, S., Vukcevic, M., Sauter, E. J., Behr, K., Ebeling, M., Dunkley, T. P. J., Friedlein, A., Zoffmann, S., Meyer, C. A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.090 · Cited by 112
Sundberg, M., Tochitsky, I., Buchholz, D. E., Winden, K. D., Kujala, V. J., Kapur, K., Cataltepe, D., Turner, D., Han, M., Woolf, C. J., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0018-4 · Cited by 120
Malformations of Cortical Development
Aronica, E., Becker, A. J., & Spreafico, R. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00581.x · Cited by 115
Self-citationAlcantara, D., Timms, A. E., Gripp, K. W., Baker, L., Park, K., Collins, S., Cheng, C. V., Stewart, F. A., Mehta, S. G., Saggar, A. K., et al. (2017) · Brain · doi:10.1093/brain/awx203 · Cited by 113
Genotype and cognitive phenotype of patients with tuberous sclerosis complex
van Eeghen, A. M., Black, M. E., Pulsifer, M. B., Kwiatkowski, D. J., & Thiele, E. A. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.241 · Cited by 102
Mühlebner, A., Bongaarts, A., Sarnat, H. B., Scholl, T. O., & Aronica, E. (2019) · Journal of Anatomy · doi:10.1111/joa.12956 · Cited by 98
Self-citationFocal malformations of cortical development: New vistas for molecular pathogenesis
Lim, K., & Crino, P. B. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.037 · Cited by 98
Self-citationEpilepsy Related to Developmental Tumors and Malformations of Cortical Development
Aronica, E., & Crino, P. B. (2014) · Neurotherapeutics · doi:10.1007/s13311-013-0251-0 · Cited by 99
Self-citationWinden, K. D., Sundberg, M., Yang, C., Wafa, S. M. A., Dwyer, S., Chen, P.-F., Buttermore, E. D., & Sahin, M. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.0642-19.2019 · Cited by 93
Way, S. W., Rozas, N. S., Wu, H. C., McKenna, J., Reith, R. M., Hashmi, S. S., Dash, P. K., & Gambello, M. J. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds156 · Cited by 94
Iffland, P. H., Carson, V., Bordey, A., & Crino, P. B. (2019) · Epilepsia · doi:10.1111/epi.16370 · Cited by 84
Self-citationMizuguchi, M., Ikeda, H., Kagitani‐Shimono, K., Yoshinaga, H., Suzuki, Y., Aoki, M., Endo, M., Yonemura, M., & Kubota, M. (2018) · Brain and Development · doi:10.1016/j.braindev.2018.07.003 · Cited by 85
Tsai, P., & Sahin, M. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32834451c4 · Cited by 84
Anderl, S., Freeland, M., Kwiatkowski, D. J., & Goto, J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr393 · Cited by 81
Crino, P. B. (2015) · Seminars in Neurology · doi:10.1055/s-0035-1552617 · Cited by 90
Self-citationTORC1‐dependent epilepsy caused by acute biallelic Tsc1 deletion in adult mice
Abs, E., Goorden, S. M. I., Schreiber, J., Overwater, I. E., Hoogeveen‐Westerveld, M., Bruinsma, C. F., Aganović, E., Borgesius, N. Z., Nellist, M. D., & Elgersma, Y. (2013) · Annals of Neurology · doi:10.1002/ana.23943 · Cited by 83
Aronica, E., & Mühlebner, A. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802395-2.00015-8 · Cited by 82
Self-citationFeliciano, D. M., Quon, J. L., Su, T., Taylor, M. M., & Bordey, A. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr511 · Cited by 79
Hino, O., & Kobayashi, T. (2016) · Cancer Science · doi:10.1111/cas.13116 · Cited by 74
Ehninger, D. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.015 · Cited by 68
The Neurodevelopmental Pathogenesis of Tuberous Sclerosis Complex (TSC)
Feliciano, D. M. (2020) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2020.00039 · Cited by 69
Current Approaches and Future Directions for the Treatment of mTORopathies
Karalis, V., & Bateup, H. S. (2021) · Developmental Neuroscience · doi:10.1159/000515672 · Cited by 67
Bolton, P., Clifford, M., Tye, C., Maclean, C. J., Humphrey, A., le Maréchal, K., Higgins, N. J., Neville, B. G. R., Rijsdjik, F., The Tuberous Sclerosis 2000 Study Group, et al. (2015) · Psychological Medicine · doi:10.1017/s0033291715000264 · Cited by 69
Normand, E. A., Crandall, S. R., Thorn, C. A., Murphy, E. M., Voelcker, B., Browning, C., Machan, J. T., Moore, C. I., Connors, B. W., & Zervas, M. (2013) · Neuron · doi:10.1016/j.neuron.2013.03.030 · Cited by 67
Moon, U. Y., Park, J. Y., Park, R., Cho, J. Y., Hughes, L. J., McKenna, J., Goetzl, L. M., Cho, S., Crino, P. B., Gambello, M. J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.013 · Cited by 69
Self-citationKim, S.-H., Speirs, C. K., Solnica‐Krezel, L., & Ess, K. C. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.005587 · Cited by 61
Hughes, J., Dawson, R., Tea, M. N., McAninch, D., Piltz, S., Jackson, D., Stewart, L., Ricos, M. G., Dibbens, L. M., Harvey, N. L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-12574-2 · Cited by 66
Somatic mutation: The hidden genetics of brain malformations and focal epilepsies
Ye, Z., McQuillan, L., Poduri, A., Green, T. E., Matsumoto, N., Mefford, H. C., Scheffer, I. E., Berkovic, S. F., & Hildebrand, M. S. (2019) · Epilepsy Research · doi:10.1016/j.eplepsyres.2019.106161 · Cited by 62
Hasbani, D. M., & Crino, P. B. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00052-1 · Cited by 58
Self-citationPicchioni, D., Reith, R. M., Nadel, J., & Smith, C. B. (2014) · Brain Sciences · doi:10.3390/brainsci4010150 · Cited by 56
Yuan, E. D., Tsai, P. T., Greene-Colozzi, E. A., Şahin, M., Kwiatkowski, D. J., & Malinowska, I. A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds262 · Cited by 55
Megalencephaly and Macrocephaly
Winden, K. D., Yuskaitis, C. J., & Poduri, A. (2015) · Seminars in Neurology · doi:10.1055/s-0035-1552622 · Cited by 55
Genomic analysis of the molecular neuropathology of tuberous sclerosis using a human stem cell model
Grabole, N., Zhang, J. D., Aigner, S., Ruderisch, N., Costa, V., Weber, F. C., Theron, M., Berntenis, N., Spleiss, O., Ebeling, M., et al. (2016) · Genome Medicine · doi:10.1186/s13073-016-0347-3 · Cited by 51
mTOR signaling in neural stem cells: from basic biology to disease
Magri, L., & Galli, R. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1196-x · Cited by 52
Zimmer, T. S., Broekaart, D. W. M., Gruber, V.-E., van Vliet, E. A., Mühlebner, A., & Aronica, E. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.01028 · Cited by 48
Self-citationAlves, M. M., Fuhler, G. M., Queiroz, K. C. S., Scholma, J., Goorden, S. M. I., Anink, J. J., Spek, C. A., Hoogeveen‐Westerveld, M., Bruno, M. J., Nellist, M. D., et al. (2015) · Scientific Reports · doi:10.1038/srep14534 · Cited by 47
Self-citationHuman TSC2-null fibroblast-like cells induce hair follicle neogenesis and hamartoma morphogenesis
Li, S., Thangapazham, R. L., Wang, J.-A., Rajesh, S., Kao, T., Sperling, L. C., Moss, J., & Darling, T. N. (2011) · Nature Communications · doi:10.1038/ncomms1236 · Cited by 45
Genotype and brain pathology phenotype in children with tuberous sclerosis complex
Overwater, I. E., Swenker, R., van der Ende, E. L., Hanemaayer, K., Hoogeveen‐Westerveld, M., van Eeghen, A. M., Lequin, M. H., van den Ouweland, A. M., Moll, H. A., Nellist, M. D., et al. (2016) · European Journal of Human Genetics · doi:10.1038/ejhg.2016.85 · Cited by 44
Delaney, S. P., Julian, L. M., & Stanford, W. L. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00069 · Cited by 40
Central TSC2 missense mutations are associated with a reduced risk of infantile spasms
van Eeghen, A. M., Nellist, M. D., van Eeghen, E. E., & Thiele, E. A. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.07.007 · Cited by 41
Precision Therapy for Epilepsy Related to Brain Malformations
D’Gama, A. M., & Poduri, A. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01122-6 · Cited by 40
Dombkowski, A. A., Batista, C. E. A., Cukovic, D., Carruthers, N. J., Ranganathan, R., Shukla, U., Stemmer, P. M., Chugani, H. T., & Chugani, D. C. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhu276 · Cited by 38
Sosunov, A. A., McGovern, R. A., Mikell, C. B., Wu, X., Coughlin, D. G., Crino, P. B., Weiner, H. L., Ghatan, S., Goldman, J. E., & McKhann, G. M. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0191-5 · Cited by 40
Self-citationResective surgery in tuberous Sclerosis complex, from Penfield to 2018: A critical review
Ostrowsky‐Coste, K., Neal, A. J., Guénot, M., Ryvlin, P., Bouvard, S., Bourdillon, P., Jung, J., Catenoix, H., Montavont, A., Isnard, J., et al. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2018.11.002 · Cited by 38
Blair, J. D., & Bateup, H. S. (2019) · Developmental Dynamics · doi:10.1002/dvdy.60 · Cited by 37
Brain Symptoms of Tuberous Sclerosis Complex: Pathogenesis and Treatment
Mizuguchi, M., Ohsawa, M., Kashii, H., & Sato, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136677 · Cited by 37
Scheldeman, C., Mills, J. D., Siekierska, A., Serra, I., Copmans, D., Iyer, A. M., Whalley, B. J., Maes, J., Jansen, A., Lagae, L. G., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.09.004 · Cited by 36
Self-citationGenomics in the presurgical epilepsy evaluation
Moloney, P. B., Dugan, P. C., Widdess‐Walsh, P., Devinsky, O., & Delanty, N. (2022) · Epilepsy Research · doi:10.1016/j.eplepsyres.2022.106951 · Cited by 35
Tuberous sclerosis complex exhibits a new renal cystogenic mechanism
Bissler, J. J., Zadjali, F., Bridges, D., Astrinidis, A., Barone, S., Yao, Y., Redd, J. R., Siroky, B. J., Wang, Y., Finley, J. T., et al. (2019) · Physiological Reports · doi:10.14814/phy2.13983 · Cited by 34
Cystogenesis and elongated primary cilia in Tsc1-deficient distal convoluted tubules
Armour, E. A., Carson, R. P., & Ess, K. C. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00141.2012 · Cited by 36
Epilepsy, impaired functioning, and quality of life in patients with tuberous sclerosis complex
Vergeer, M., de Ranitz‐Greven, W. L., Neary, M. P., Ionescu‐Ittu, R., Émond, B., Duh, M. S., Jansen, F. E., & Zonnenberg, B. A. (2019) · Epilepsia Open · doi:10.1002/epi4.12365 · Cited by 30
Gataullina, S., Lemaire, É., Wendling, F., Kamińska, A., Françoise Watrin, A., Riquet, A., Ville, D. M., Moutard, M., Martin, A. D. S., Napuri, S., et al. (2016) · Epilepsia · doi:10.1111/epi.13325 · Cited by 29
The role of somatic mutational events in the pathogenesis of epilepsy
Iffland, P. H., & Crino, P. B. (2019) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000667 · Cited by 28
Self-citationZimmer, T. S., Korotkov, A., Zwakenberg, S., Jansen, F. E., Zwartkruis, F. J. T., Rensing, N. R., Wong, M., Mühlebner, A., van Vliet, E. A., Aronica, E., et al. (2021) · Brain Pathology · doi:10.1111/bpa.12949 · Cited by 27
Self-citationMechanistic target of rapamycin signaling in human nervous system development and disease
Girodengo, M., Ultanir, S. K., & Bateman, J. E. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1005631 · Cited by 28
Tuberous sclerosis complex: new insights into clinical and therapeutic approach
Volpi, A., Sala, G., Lesma, E. A., Labriola, F. S., Righetti, M., Alfano, R. M., & Cozzolino, M. G. (2018) · Journal of Nephrology · doi:10.1007/s40620-018-0547-6 · Cited by 25
Bhattacharya, A., Choi, W. W. Y., Muffat, J., & Li, Y. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167386 · Cited by 24
Happle, R., & Torrelo, A. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16603 · Cited by 23
Boronat, S., Thiele, E. A., & Caruso, P. A. (2017) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.13499 · Cited by 22
Dendrite growth and the effect of ectopic Rheb expression on cortical neurons
Sokolov, A. M., Seluzicki, C. M., Morton, M. C., & Feliciano, D. M. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.02.021 · Cited by 24
Potential for treatment of severe autism in tuberous sclerosis complex
Gipson, T. (2013) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v2.i3.16 · Cited by 21
Animal models and human tissue compared to better understand and treat the epilepsies
Milior, G., Morin‐Brureau, M., Pallud, J., Miles, R., & Huberfeld, G. (2023) · Epilepsia · doi:10.1111/epi.17552 · Cited by 20
Progress of Induced Pluripotent Stem Cell Technologies to Understand Genetic Epilepsy
Sterlini, B., Fruscione, F., Baldassari, S., Benfenati, F., Zara, F., & Corradi, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020482 · Cited by 19
Pancreatic Neuroendocrine Tumor in a Young Child With Tuberous Sclerosis Complex 1
Mehta, S., Rusyn, L., Ginsburg, H. B., Hajdu, C. H., & Kohn, B. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00051 · Cited by 18
Cerebral organoids as an in vitro model to study autism spectrum disorders
Rabeling, A., & Goolam, M. (2022) · Gene Therapy · doi:10.1038/s41434-022-00356-z · Cited by 17
McKenna, J., Kapfhamer, D., Kinchen, J. M., Wasek, B. L., Dunworth, M., Stewart, T. M., Bottiglieri, T., Casero, R. A., & Gambello, M. J. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy118 · Cited by 16
The molecular genetics of PI3K/PTEN/AKT/mTOR pathway in the malformations of cortical development
Ma, Q., Chen, G., Li, Y., Guo, Z., & Zhang, X. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.04.041 · Cited by 18
Hemimegalencephaly and tuberous sclerosis complex: A rare yet challenging association
Sidira, C., Vargiami, E., Dragoumi, P., & Zafeiriou, D. (2020) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2020.12.007 · Cited by 16
Wang, F., Xiong, S., Wu, L., Chopra, M., Hu, X., & Wu, B. (2018) · BMC Medical Genetics · doi:10.1186/s12881-018-0611-z · Cited by 14
Boronat, S., Caruso, P. A., & Thiele, E. A. (2014) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.12523 · Cited by 13
Tuberous sclerosis complex as a model disease for developing new therapeutics for epilepsy
Jeong, A., & Wong, M. (2016) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2016.1151788 · Cited by 12
Winden, K. D., Bebin, E. M., Jeste, S., Krueger, D. A., Paul, E., & Sahin, M. (2026) · Nature Reviews Disease Primers · doi:10.1038/s41572-026-00688-9 · Cited by 12
Tsc1 haploinsufficiency is sufficient to increase dendritic patterning and Filamin A levels
Zhang, L., Huang, T., & Bordey, A. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.06.037 · Cited by 11
GluN2C selective inhibition is a target to develop new antiepileptic compounds
Gataullina, S., Galvani, G., Touchet, S., Nous, C., Lemaire, É., Laschet, J. J., Chiron, C., Dulac, O., Dossi, E., Brion, J., et al. (2022) · Epilepsia · doi:10.1111/epi.17396 · Cited by 10
Robens, B. K., Grote, A., Pitsch, J., Schoch, S., Cardoso, C., & Becker, A. J. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.006 · Cited by 10
Observation of a Possible Successful Treatment of DEPDC5-Related Epilepsy with mTOR Inhibitor
Hadzsiev, K., Hegyi, M., Fogarasi, A., Bodó-Baltavári, T., Zsigmond, A., Maász, A., Szabó, A., & Till, Á. (2023) · Neuropediatrics · doi:10.1055/a-2104-1614 · Cited by 9
Metadata
- Authors
- Crino, P. B., Aronica, E., Baltuch, G., & Nathanson, K. L.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Venue
- Neurology
- Published
- 2010-05-25
- Volume
- 74
- Issue
- 21
- Pages
- 1716-1723
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC2882213
- OpenAlex
- W2109996787
- Cited by
- 153
- References
- 27
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 3 · 2023: 8 · 2022: 7 · 2021: 10 · 2020: 8 · 2019: 10 · 2018: 12 · 2017: 11 · 2016: 13 · 2015: 13 · 2014: 11 · 2013: 8 · 2012: 13
- FWCI
- 7.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- Universiteit van Amsterdam
- Erasmus Medisch Centrum
- National Cancer Institute (R01CA118871, R01CA114478)
- National Institute of Neurological Disorders and Stroke (R01NS048557, R01NS045021)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Dermatology › Genetic and rare skin diseases.
- Keywords
- tuberous sclerosis complex, TSC1, TSC2, germline mutations, somatic mutations, two-hit mechanism, tuberization, mTORC1 signaling, S6 phosphorylation, giant cells, loss of heterozygosity, nonsense mutation, missense mutations, nonsense-mediated mRNA decay, transcript expression
- MeSH terms
- Tuberous Sclerosis Complex 1 Protein, Tuberous Sclerosis Complex 2 Protein, Adolescent, Brain, DNA Mutational Analysis, Exons, Female, Humans, Male, Mutation, RNA, Messenger, Tuberous Sclerosis, Loss of Heterozygosity, Tumor Suppressor Proteins, Ribosomal Protein S6, Microdissection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
